Ray-Jade Chen Selected Research

MicroRNAs (MicroRNA)

9/2021	miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.
11/2020	Inhibition of cell death-inducing p53 target 1 through miR-210-3p overexpression attenuates reactive oxygen species and apoptosis in rat adipose-derived stem cells challenged with Angiotensin II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ray-Jade Chen Research Topics

Disease

22	Cardiomegaly (Heart Hypertrophy) 07/2022 - 02/2014
20	Neoplasms (Cancer) 01/2023 - 10/2006
19	Hypertrophy 07/2022 - 08/2008
17	Wounds and Injuries (Trauma) 12/2023 - 06/2002
15	Fibrosis (Cirrhosis) 08/2022 - 08/2008
13	Hypertension (High Blood Pressure) 12/2022 - 01/2017
11	Appendicitis 11/2017 - 02/2003
8	Inflammation (Inflammations) 12/2023 - 11/2015
7	Thrombosis (Thrombus) 01/2023 - 12/2012
7	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 01/2013
7	Hypoxia (Hypoxemia) 11/2020 - 01/2016
6	Cardiotoxicity 02/2022 - 02/2019
6	Infections 01/2020 - 05/2013
6	Heart Diseases (Heart Disease) 12/2018 - 01/2013
5	Hemorrhage 09/2022 - 06/2003
5	Heart Failure 01/2022 - 01/2015
5	Neoplasm Metastasis (Metastasis) 08/2017 - 12/2008
3	Ischemia 12/2023 - 09/2004
3	Hyperglycemia 08/2022 - 01/2021
3	Cardiomyopathies (Cardiomyopathy) 11/2019 - 01/2019
3	Hyperlipidemias (Hyperlipidemia) 01/2018 - 01/2016
3	Colonic Neoplasms (Colon Cancer) 08/2017 - 02/2017
3	Abscess 10/2016 - 01/2003
2	Body Weight (Weight, Body) 07/2022 - 05/2017
2	Alzheimer Disease (Alzheimer's Disease) 07/2022 - 01/2018
2	Heart Injuries 02/2022 - 08/2021
2	Lymphoma (Lymphomas) 09/2021 - 03/2017
2	Hepatocellular Carcinoma (Hepatoma) 02/2021 - 02/2018
2	COVID-19 01/2021 - 01/2020
2	Peritonitis 10/2020 - 09/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2020 - 01/2013
2	Diabetes Mellitus 05/2020 - 01/2018
2	Disease Progression 03/2020 - 12/2015
2	Ascites 01/2020 - 03/2007
2	Shock 09/2019 - 01/2019
2	Reperfusion Injury 01/2019 - 09/2004
2	Glioma (Gliomas) 01/2018 - 02/2016
2	Glioblastoma (Glioblastoma Multiforme) 11/2017 - 02/2016
2	Sepsis (Septicemia) 10/2017 - 01/2003
2	Brain Injuries (Brain Injury) 07/2017 - 04/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2017 - 04/2016

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2015
14	Angiotensin IIIBA 12/2022 - 01/2013
6	Atrial Natriuretic Factor (ANF)IBA 07/2022 - 03/2016
6	CalcineurinIBA 02/2022 - 01/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2003
4	AntioxidantsIBA 08/2022 - 09/2004
4	Mitogen-Activated Protein KinasesIBA 02/2022 - 02/2016
4	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2021 - 08/2008
4	transcription factor NF-AT c3IBA 09/2021 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 01/2016
4	Estrogen ReceptorsIBA 10/2019 - 01/2013
4	Matrix Metalloproteinases (MMPs)IBA 08/2017 - 11/2012
3	CollagenIBA 08/2022 - 02/2019
3	Arecoline (Arecolin)IBA 02/2022 - 01/2021
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
3	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 12/2021 - 02/2018
3	Sirtuin 1IBA 09/2021 - 01/2018
3	Insulin-Like PeptidesIBA 07/2021 - 03/2016
3	Therapeutic UsesIBA 01/2021 - 01/2019
3	ResveratrolIBA 05/2020 - 01/2018
3	CateninsIBA 09/2019 - 01/2017
3	Galactose (Galactopyranose)FDA LinkGeneric 12/2018 - 03/2016
3	TeaIBA 07/2018 - 01/2016
3	LipidsIBA 01/2018 - 10/2015
3	Cetuximab (Erbitux)FDA Link 11/2017 - 04/2016
3	p38 Mitogen-Activated Protein KinasesIBA 08/2017 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 05/2017 - 12/2015
3	Estrogens (Estrogen)FDA Link 04/2017 - 01/2013
3	Indicators and Reagents (Reagents)IBA 01/2017 - 06/2002
3	C-Reactive ProteinIBA 01/2006 - 04/2005
2	Glycoproteins (Glycoprotein)IBA 09/2022 - 02/2022
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2022 - 01/2018
2	SaponinsIBA 02/2022 - 02/2021
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2021 - 09/2021
2	MicroRNAs (MicroRNA)IBA 09/2021 - 11/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 10/2015
2	ORALIT (ORS)IBA 01/2020 - 07/2015
2	LipopolysaccharidesIBA 11/2019 - 10/2019
2	SaltsIBA 02/2019 - 01/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 03/2016
2	Small Interfering RNA (siRNA)IBA 01/2018 - 03/2017
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2018 - 01/2016
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2018 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 11/2017 - 05/2017

Therapy/Procedure

17	Therapeutics 12/2022 - 10/2006
10	Appendectomy 11/2017 - 02/2003
7	Laparotomy 10/2020 - 06/2003
5	Resuscitation 01/2019 - 10/2008
3	Length of Stay 01/2020 - 01/2003
3	Splenectomy 10/2017 - 08/2003
3	Pancreatectomy 10/2017 - 08/2003
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017 - 01/2013
3	Blood Transfusion (Blood Transfusions) 07/2014 - 01/2003
2	Oral Administration 07/2021 - 01/2021
2	Autologous Transplantation 05/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 03/2020 - 05/2017
2	Stents 09/2019 - 01/2003
2	Pancreaticojejunostomy 10/2017 - 04/2004